[Food intake-suppressing action of incretin and anti-obesity therapy].
Nihon Rinsho
; 69(5): 826-30, 2011 May.
Article
en Ja
| MEDLINE
| ID: mdl-21595266
ABSTRACT
Suppressing food intake is the most well-known central nervous action of glucagon-like peptide-1 (GLP-1). Neurons expressing preproglucagon (PPG) in the nucleus tractus solitarius (NTS) are the only source of "central" GLP-1, and they project to the hypothalamus. Recently, properties of these PPG-neurons have been revealed using transgenic mice expressing fluorescent protein under control of the PPG promoter; whereas they are directly responsible to leptin but not to GLP-1, they can be the second-order neurons of vagal afferents. "Peripheral" GLP-1 released from intestinal L-cells may possess central nervous action through the vagal afferent fibers. The question remains whether food intake suppression due to "peripheral" GLP-1 depends on "central" one. The action is being applied to anti-obesity therapy.
Buscar en Google
Banco de datos:
MEDLINE
Asunto principal:
Apetito
/
Péptido 1 Similar al Glucagón
/
Oxintomodulina
/
Obesidad
Límite:
Animals
/
Humans
Idioma:
Ja
Año:
2011
Tipo del documento:
Article